Affymax to Present at the Lazard Capital Markets Healthcare Conference
Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the
company's chief executive officer, will present at the Lazard Capital
Markets 9TH Annual Healthcare Conference on Wednesday,
November 14, 2012 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) in
New York City.
A live webcast of the presentation will be available on the investors
section of the Company's website at http://www.investors.affymax.com/events.cfm.
A replay will also be available for 30 days following the presentation.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto,
California. Affymax's mission is to discover, develop and deliver
innovative therapies that improve the lives of patients with kidney
disease and other serious and often life-threatening illnesses.
The company's first marketed product, OMONTYS® (peginesatide)
Injection, was approved by the U.S. Food and Drug Administration (FDA)
in March 2012. For additional information, please visit www.affymax.com.
Corporate Contact: Affymax, Inc. Alexandra Santos,
650-812-8961 Associate Director, Corporate Communications